News

2 Bridge is attending BioEquity and Knowledge for Growth

25 April 18

We are pleased to announce that 2 Bridge will be present at the next edition of Bio€quity and Knowledge for Growth, organized in Ghent, from May 14th – May 17th, 2018. We are very much looking forward to meeting you this week.

2 Bridge receives French Research Tax Credit accreditation (CIR)

20 April 18

We are pleased to inform you that the French Ministry of Higher Education, Research and Innovation has granted our company the French Research Tax Credit accreditation.

Microbiome – White Paper

16 March 18

Changes in the gut microbiome are associated with numerous diseases. Research shows – convincingly – that microbiome modulation may lead to a cure. Why is it then, that the efforts to treat patients by targeting the gut microbiome fail?

2 Bridge on the 2018 Belgian State Visit to Canada

12 March 18

We proudly announce that Ann Meulemans, CEO & Managing Partner of 2 Bridge, is taking part in the Belgian State Visit to Canada.

January New Hires

27 February 18

2 Bridge keeps on growing.
We are pleased to have welcomed three new team members in January, 2018.

How can you minimize the impact that Drug Transporters have on your project?

08 December 17

In just 3 pages you will learn which aspects to consider when progressing your small molecule project  through Development.

2 Bridge has welcomed a new team member

15 November 17

2 Bridge has welcomed Ronald van Brempt, Medical Doctor, as new team member.

2 Bridge is attending Immunity for Health

11 September 17

Our colleague Lien Lybaert, Scientific Project Manager, is attending the second edition of Immunity for Health in Antwerp on October 20th, 2017.

2 Bridge is attending the Global Precision Medicine & Biomarkers Leaders Summit in Munich

06 September 17

Our 2 Bridge colleague, Maarten Huisman, Preclinical Director, is attending the 4th Global Precision Medicine & Biomarkers Leaders Summit taking place in Munich, Germany, on Sept 21-22, 2017.